Richard J. Jones - Concepedia

Author

Richard J. Jones

Johns Hopkins University ORCID

Also Known As

Janine Hurst, Karp, Judith, R J Jones, R J. Jones, R Jones, R. J. Jones, R. Jones, R.J Jones, R.J. JONES, R.J. Jones

496

Publications

24.2K

Citations

H-Index

120

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine Johns Hopkins Hospital Medical College of Wisconsin

About

Richard J. Jones is an author at Johns Hopkins University specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	75	6.5K
2	Health Sciences	20	26	1.7K
3	Natural Sciences	3	3	367
4	Allergy	2	2	25
5	Public Health	1	1	251

Richard J. Jones

202

Publications

21.1K

Citations

H-Index

Page 1

	Year	Citations
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Biology of Blood and Marrow Transplantation	2008	1.9K
Characterization of clonogenic multiple myeloma cells William Matsui, Carol Ann Huff, Qiuju Wang, Blood	2003	788
Decreased Erythropoietin Response in Patients with the Anemia of Cancer Carole B. Miller, Richard J. Jones, Steven Piantadosi, New England Journal of Medicine AnemiaHematological MalignancyIron-deficiency AnemiaOncologyBone Marrow Failure	1990	669
Inhibition of apoptosis during development of colorectal cancer. A Bedi, Pankaj J. Pasricha, Adil Akhtar, PubMed Tumor BiologyColorectal CancersMedicineApoptosisColorectal Tumorigenesis	1995	548
Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance William Matsui, Qiuju Wang, James Barber, Cancer Research	2008	536
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide Paul V. O’Donnell, Leo Luznik, Richard J. Jones, Biology of Blood and Marrow Transplantation ImmunologyImmunotherapyPosttransplantation CyclophosphamideHematological MalignancyBone Marrow Failure	2002	474
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu, New England Journal of Medicine	2023	460
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Blood	2012	433
Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells Richard J. Jones, John E. Wagner, P Celano, Nature Induced Pluripotent Stem CellDevelopmental BiologySpleen Colony-forming CellsMedicineStem Cell Mobilization	1990	407
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation Louise B. Grochow, Richard J. Jones, Robert B. Brundrett, Cancer Chemotherapy and Pharmacology TransplantationHematologyPharmacologyVeno-occlusive DiseaseClinical Pharmacology	1989	405

Page 1